Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s00508-015-0842-3 http://scihub22266oqcxt.onion/10.1007/s00508-015-0842-3 C4679104!4679104!26373748     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Wien+Klin+Wochenschr 2015 ; 127 (23): 907-19 Nephropedia Template TP {{tp|p=26373748|t=2015. Iron metabolism and iron supplementation in cancer patients |pdf=|usr=}}{{26373748}} gab.com Text Iron metabolism and iron supplementation in cancer patients JO: Wien Klin Wochenschr http://www.kidney.de/pget.php?&tw=1&pmid=26373748 #FOAvip Iron deficiency and iron deficiency-associated anemia are common complications in cancer patients. Most iron deficient cancer patients present with functional iron deficiency (FID), a status with adequate storage iron, but insufficient iron supply for erythroblasts and other iron dependent tissues. FID is the consequence of the cancer-associated cytokine release, while in absolute iron deficiency iron stores are depleted resulting in similar but often more severe symptoms of insufficient iron supply. Here we present a short review on the epidemiology, pathophysiology, diagnosis, clinical symptoms, and treatment of iron deficiency in cancer patients. Special emphasis is given to intravenous iron supplementation and on the benefits and limitations of different formulations. Based on these considerations and recommendations from current international guidelines we developed recommendations for clinical practice and classified the level of evidence and grade of recommendation according to the principles of evidence-based medicine. Twit Text FOAVip Iron metabolism and iron supplementation in cancer patients ????Wien Klin Wochenschr http://www.kidney.de/pget.php?&tw=1&pmid=26373748 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=26373748 #FOAvip English Wikipedia <ref>{{Cite pmid|26373748}}</ref> Iron metabolism and iron supplementation in cancer patients #MMPMID26373748 Ludwig H; Evstatiev R; Kornek G; Aapro M; Bauernhofer T; Buxhofer-Ausch V; Fridrik M; Geissler D; Geissler K; Gisslinger H; Koller E; Kopetzky G; Lang A; Rumpold H; Steurer M; Kamali H; Link H Wien Klin Wochenschr 2015[]; 127 (23): 907-19 PMID26373748show ga Iron deficiency and iron deficiency-associated anemia are common complications in cancer patients. Most iron deficient cancer patients present with functional iron deficiency (FID), a status with adequate storage iron, but insufficient iron supply for erythroblasts and other iron dependent tissues. FID is the consequence of the cancer-associated cytokine release, while in absolute iron deficiency iron stores are depleted resulting in similar but often more severe symptoms of insufficient iron supply. Here we present a short review on the epidemiology, pathophysiology, diagnosis, clinical symptoms, and treatment of iron deficiency in cancer patients. Special emphasis is given to intravenous iron supplementation and on the benefits and limitations of different formulations. Based on these considerations and recommendations from current international guidelines we developed recommendations for clinical practice and classified the level of evidence and grade of recommendation according to the principles of evidence-based medicine. äIron metabolism and iron supplementation in cancer patients (epmc).pdf DeepDyve Pubget Overpricing